The Vanguard Group, Inc. has recently announced that it has increased stake in Select Medical Holdings Corporation (NYSE:SEM) by 0.51%. After grabbing 11.7 million shares, the institutional investor is now in possession of 59002.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.13% having worth around $264.41 million. Moreover, Hood River Capital Management LLC increased its share by 48779.0 to have a control over 2.17 million shares. And Geode Capital Management LLC raised its holdings to 78164.0 shares by acquiring 2.08 million shares or 1.63% of the stake.
Select Medical Holdings Corporation (SEM) concluded trading on 01/04/24 at a closing price of $26.15, with 3.24 million shares of worth about $84.68 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.83% during that period and on Thursday the price saw a gain of about 11.28%. Currently the company’s common shares owned by public are about 127.17M shares, out of which, 101.38M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the SEM stock and their offered price forecasts bring an average price target of $32.80. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $40.00 and could fall to a lowest price of $26.00. The stock’s current price level is 20.27% above of average price target set by the analysts, while a rise to estimated low would result in loss of -0.58% for the stock. However, touching the estimated high of $40.00 would mean a gain of 34.63% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 58 times over the past 12 months. They bought 1,805,097 shares in 34 of the transactions. In 24 selling transactions, insiders dumped 3,143,196 shares.
T Rowe Price Mid Cap Value Fund, iShares Core S&P Small Cap ETF, and T Rowe Price Small Cap Value Fund are the top 3 mutual funds which are holding stakes in Select Medical Holdings Corporation T Rowe Price Mid Cap Value Fund is currently holding 9.65 million shares of worth totaling $218.17 million. The company recently came selling -1.24 million shares which brought its stake up to 7.53% of the company’s outstanding shares. iShares Core S&P Small Cap ETF bought 3396.0 shares, after which its hold over company’s outstanding shares expand to 5.44%, leaving 6.98 million shares with the mutual fund that have a worth of about $157.68 million. T Rowe Price Small Cap Value Fund, after selling 3.81 million shares, have now control over 2.97% of the stake in the company. It holds 41600.0 shares of worth $86.11 million.
Select Medical Holdings Corporation (NYSE: SEM) started trading at $23.78, above $0.28 from concluding price of the previous day. Stock saw a price change of 9.23% in past 5 days and over the past one month there was a price change of 9.55%. Year-to-date (YTD), SEM shares are showing a performance of 11.28% which increased to 5.32% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $21.28 but also hit the highest price of $33.51 during that period. The average intraday trading volume for Select Medical Holdings Corporation shares is 594.32K. The stock is currently trading 9.47% above its 20-day simple moving average (SMA20), while that difference is up 12.42% for SMA50 and it goes to -2.49% lower than SMA200.
The Vanguard Group, Inc. acquired 11.7 million shares of Select Medical Holdings Corporation having value of about $264.41 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 59002.0 shares in the company valued at close to $1542902.3, or have control over 0.51% stake in the company. Select Medical Holdings Corporation (NYSE: SEM) currently have 127.17M outstanding shares and institutions hold larger chunk of about 76.07% of that. Holding of mutual funds in the company is about 38.23% while other institutional holders and individual stake holders have control over 49.32% and 26.84% of the stake respectively.
The stock has a current market capitalization of $3.35B and its 3Y-monthly beta is at 1.35. PE ratio of stock for trailing 12 months is 14.89, while it has posted earnings per share of $1.76 in the same period. Its PEG reads 0.47 and has Quick Ratio of 1.09 while making debt-to-equity ratio of 3.96. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SEM, volatility over the week remained 5.44% while standing at 3.41% over the month.
Analysts are in expectations that Select Medical Holdings Corporation (SEM) stock would likely to be making an EPS of $0.35 in the current quarter, while forecast for next quarter EPS is $0.61 and it is $2.27 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.32 which is $0.39 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.22 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 61.01% while it is estimated to increase by 13.52% in next year. EPS is likely to grow at an annualized rate of 31.82% for next 5-years, compared to annual growth of -1.50% made by the stock over the past 5-years.
Analysts at 5 brokerage firms have issued recommendations for the Select Medical Holdings Corporation (SEM)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.40. Out of those 5 Wall Street analysts, 4 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by The Benchmark Company on May 13, 2021 offering a Buy rating for the stock and assigned a target price range of between $40 and $44 to it.
